免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Achilles Non-SNIS REGENETEN

NCT:NCT07869121 · ENROLLING_BY_INVITATION

NCT IDNCT07869121
狀態ENROLLING_BY_INVITATION
開始日期2026-08-03
完成時間2028-12-31
SponsorOrthoCarolina Research Institute, Inc. (OTHER)
First posted
Last updated

簡要摘要

The proposed study addresses this gap by prospectively evaluating patient-reported outcomes, imaging endpoints, and safety through 12 months after BCI-augmented repair in IAT and MSR patients. The purpose is to evaluate clinical outcomes (effectiveness) following the use of REGENETEN to augment Achilles tendon surgical procedures.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑